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The X-ray structure of Brassica napus β-keto acyl carrier protein
reductase and its implications for substrate binding and catalysis
Martin Fisher1, Johan TM Kroon2, Wayne Martindale2, Antoine R Stuitje3,
Antoni R Slabas2 and John B Rafferty1*
Background: β-Keto acyl carrier protein reductase (BKR) catalyzes the
pyridine-nucleotide-dependent reduction of a 3-oxoacyl form of acyl carrier
protein (ACP), the first reductive step in de novo fatty acid biosynthesis and a
reaction often performed in polyketide biosynthesis. The Brassica napus BKR
enzyme is NADPH-dependent and forms part of a dissociable type II fatty acid
synthetase (FAS). Significant sequence similarity is observed with enoyl acyl
carrier protein reductase (ENR), the other reductase of FAS, and the 
short-chain alcohol dehydrogenase (SDR) family.
Results: The first crystal structure of BKR has been determined at 2.3 Å
resolution in a binary complex with an NADP+ cofactor. The structure reveals a
homotetramer in which each subunit has a classical dinucleotide-binding fold.
A triad of Ser154, Tyr167 and Lys171 residues is found at the active site,
characteristic of the SDR family. Overall BKR has a very similar structure to
ENR with good superimposition of catalytically important groups. Modelling of
the substrate into the active site of BKR indicates the need for conformational
changes in the enzyme.
Conclusions: A catalytic mechanism can be proposed involving the conserved
triad. Helix α6 must shift its position to permit substrate binding to BKR and
might act as a flexible lid on the active site. The similarities in fold, mechanism
and substrate binding between BKR, which catalyzes a carbon–oxygen 
double-bond reduction, and ENR, the carbon–carbon double-bond
oxidoreductase in FAS, suggest a close evolutionary link during the
development of the fatty acid biosynthetic pathway.
Introduction
A complex enzyme system, fatty acid synthetase (FAS), is
used throughout nature for the de novo biosynthesis of
fatty acids from acetyl CoA and malonyl CoA. The mol-
ecular organization of FAS is species-dependent [1]. In
the type I FAS of vertebrates, yeast and some bacteria,
one or two multidomain polypeptides catalyze the differ-
ent steps of the fatty acid elongation cycle, whereas in the
type II FAS of plants and many bacteria, including
Escherichia coli, the individual enzymatic functions are
located on discrete polypeptide chains. The growing acyl
chain is optimally supplied to the active sites of the
enzymes bound to an acyl carrier protein (ACP), which is
also part of the multidomain polypeptide system in type I
FAS. β-Keto acyl carrier protein reductase (BKR) cat-
alyzes the pyridine-nucleotide-dependent reversible
reduction of a 3-oxoacyl form of ACP to its hydroxy
product as the first reductive step in de novo fatty acid
biosynthesis [2]. The Brassica napus BKR enzyme forms
part of a dissociable type II FAS and catalyzes an
NADPH-dependent reduction [3], where the product of
the reduction is the R-3-hydroxyacyl isomer [4]. BKR can
also catalyze the reduction of the β-keto group of unsatu-
rated acyl chains during the biosynthesis of unsaturated
fatty acids in E. coli [5]. The natural substrate of BKR is
acylated ACP, but the enzyme will also act upon acylated
CoA and acylated cysteamine [3].
Sequence comparisons have shown that BKR belongs to a
short-chain alcohol dehydrogenase (SDR) family [6], which
possesses a characteristic Ser-Tyr-Lys triad motif involved
in catalysis and substrate binding. BKR also shows a
notable sequence similarity to the other oxidoreductase of
the fatty acid elongation cycle, enoyl acyl carrier protein
reductase (ENR). Although ENR does not have the cat-
alytic triad seen in the SDR family, it is still believed to
utilize conserved tyrosine and lysine residues during catal-
ysis [6]. However, BKR and ENR catalyze distinctly differ-
ent chemical reactions, namely a carbon–oxygen
double-bond reduction and a carbon–carbon double-bond
reduction, respectively. 
This paper reports the first structure determination of a
BKR, that of the B. napus enzyme at 2.3 Å resolution.
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The evolutionary link with the fatty acid biosynthetic
enzyme ENR and a model for substrate binding and
catalysis are discussed.
Results and discussion
Subunit structure
The BKR subunit comprises a single domain of dimen-
sions 40 × 40 × 50 Å and all of the polypeptide chain could
be traced through the map except for the first 16 residues.
The model has good overall stereochemistry and a
Ramachandran plot of the structure shows that all non-
glycine residues lie within the allowed regions (90% in the
most favoured regions and 10% in allowed regions). The
subunit is formed from seven β strands (β1–β7), creating a
parallel β sheet, eight α helices (α1–α8), and a number of
loops of varying length that modify the functional charac-
teristics of the enzyme. The secondary structure was
defined using the program PROMOTIF [7] and 64% of
the residues are found in the secondary structure elements
(48% α helix and 16% β strand). The parallel β sheet is
flanked on one side by helices α1, α2 and α8 and on the
other side by helices α3, α4 and α5. Helix α6 lies ‘above’
the sheet such that its helical axis points approximately
towards the pyrophosphate moiety of a bound NADP+
nucleotide cofactor, and α7 sits along the ‘top edge’ of the
β sheet above the C-terminal ends of strands β1 and β7
(Figure 1). The fold is that commonly found in dinu-
cleotide-binding enzymes [8].
A multiple sequence alignment of BKR from B. napus,
E. coli, Vibrio harveyi, Haemophilus influenzae, Cuphea lance-
olata and Arabidopsis thaliana (Figure 2) reveals that 87
residues (33% of the 260 in B. napus BKR) are completely
conserved, and a further 25 residues are strongly con-
served (i.e. occurring in B. napus and four out of the five
other sequences). When the completely conserved
residues are mapped onto the three-dimensional struc-
ture of the B. napus enzyme, they can be seen to lie
within the core of the subunit formed by the central
three strands (β4–β6) of the β sheet, around the binding
site for the nucleotide cofactor and in a solvent-exposed
surface region expected to bind the growing acyl tail of
the substrate.
Quaternary structure
Gel-filtration studies on BKR are consistent with it being
a tetramer in oilseed rape [3], spinach [4] and avocado [9],
and in the packing in the crystal there is an obvious
tetramer with approximate dimensions 80 × 80 × 70 Å
(Figure 1c). Each monomer in the tetramer makes contact
with all three symmetry-related partners. The solvent-
accessible surface areas of an isolated monomer and a
tetramer have been calculated using the program
AREAIMOL [10] with a probe radius of 1.4 Å and are
approximately 11,000 Å2 and 30,000 Å2, respectively.
Therefore, on formation of the tetramer, approximately
3500 Å2 (32%) of the solvent-accessible surface is buried
per monomer. The tetramer has 222 symmetry and thus
there are three different intersubunit interfaces about
three orthogonal molecular twofold axes (often designated
P, Q and R in tetrameric dinucleotide-binding enzymes).
About the P axis, a total of approximately 2000 Å2 (18%) of
solvent-accessible surface is buried per monomer and
there is a hydrophobic-packing interaction between the
α8 helices and a series of sidechain to mainchain hydro-
gen-bond contacts between the β7 strands from adjacent
parallel β sheets. These interactions are supplemented by
additional contacts involving residues from the turn pre-
ceding strand β6, the loops preceding and following helix
α8 and the C-terminal residues following strand β7. A
four-helix bundle is formed about the Q axis by the α4
and α5 helices and a total of approximately 1600 Å2 (15%)
of solvent-accessible surface is buried per monomer. This
interface involves direct hydrogen bonds between
residues in helix α4 and its preceding turn and residues in
helix α5 and the loop between strand β5 and helix α5.
Around the R axis a very small interface is formed, which
buries a total of approximately 110 Å2 (1%) of solvent-
accessible surface, mainly owing to hydrophobic-packing
interactions made by the loop following strand β5 and the
C-terminal residue.
Dinucleotide-binding site
The structure of B. napus BKR was determined from
cocrystals of a binary complex with NADP+. Analysis of
the binary complex shows that the cofactor is bound in an
extended conformation at the C-terminal ends of the
β strands in a manner commonly seen for dinucleotide-
binding enzymes (Figure 3a). Both ribose sugar rings are
found as the C2′-endo conformer.
The adenine ring binds in a pocket that is formed by the
sidechains of Asn47, Ala49, Val76, Ser77, Ala103 and
Leu125. Direct hydrogen bonds are formed between the
adenine nitrogen atom at position N1 and NH of Val76
and between N6 and the sidechain of Asp75.
The 3′ adenine ribose hydroxyl group forms a direct
hydrogen bond to NH of Arg27 and to the sidechain of
Ser26. Ser26 is also involved in the stabilization of the
phosphate moiety bound to the 2′ adenine ribose
hydroxyl which sits in a pocket formed by the sidechains
of Ser26, Arg27, Tyr48 and Ser51 and the mainchain
between Tyr48 and Ser51. Direct hydrogen bonds are
formed from the phosphate group to the sidechains of
Ser26 and Ser51, NH of Ala49, NH of Ala50, NH of Ser51
and to a solvent molecule. The positively charged guani-
dino group of Arg27 is approximately 3.6 Å from the phos-
phate group and helps to stabilize its negative charge. A
common method for recognizing the adenine ribose
hydroxyl groups in nucleotide-binding enzymes employs
hydrogen bonds from the sidechain of an acidic residue on
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an adjacent β strand, which is linked in turn to the loop
between strand β1 and helix α1. In BKR, where a nega-
tively charged acidic residue might interfere with
NADP(H) binding, the equivalent residue is Ala49.
The pyrophosphate moiety of the NADP+ lies close to
residues at the C-terminal end of the β sheet where interac-
tions are formed with the glycine-rich region that forms the
loop between β1 and α1, the so-called nucleotide-binding
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Figure 1
The overall fold of Brassica napus BKR.
(a) Stereoview of the Cα backbone of a
monomer with every tenth residue labelled.
(The figure was produced using MIDAS [35].)
Schematic stereoview representations of the
fold of (b) a monomer and (c) a tetramer with
α helices and β strands shown as labelled
coils and arrows (magenta and cyan in (b); red
and green in (c)), respectively. The nucleotide
cofactor has been omitted for clarity and in (c)
individual subunits of the tetramer are labelled
A–D. (The figures were produced using
MolScript [36] and Raster3D [37].)
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helix. The pyrophosphate moiety of the nucleotide makes
a number of direct or solvent-mediated hydrogen bonds to
the protein: O1P via solvent to O Gly104, O2P via solvent
to NH Asp203, O4P to the sidechain of Ser202, O5P to NH
Ile29 and via solvent to NH Gly30, to O Arg27 and to the
sidechain of Asn102. The charge on the pyrophosphate
moiety is additionally stabilized by the helical dipole of α1
and the guanidino group of Arg27, which is approximately
4.2 Å away.
Catalytic mechanism
A common theme has been derived for the mechanism of
action of many of the oxidoreductases of the SDR family,
to which BKR belongs, and involves a catalytic triad of
conserved serine, tyrosine and lysine residues [11–13].
The catalytic mechanism of the reduction proceeds via a
hydride transfer from the nucleotide followed by proton
donation from a nearby tyrosine phenolic hydroxyl group.
Thus by analogy, a plausible mechanism for the reduction
by BKR of its 3-oxoacyl substrate can be envisaged in
which there is an attack of a hydride ion from NADPH
upon the carbon of the keto group at position C3 followed
by the formation of an alkoxide ion intermediate
(Figure 3b). In a subsequent step, a proton could then be
donated to the oxygen of the alkoxide ion to give the
reduced secondary alcohol product. Examination of the
region in BKR close to the position of the C4 of the nico-
tinamide ring of the NADP+ confirms that the conserved
Tyr167 and Lys171 residues are appropriately positioned
to support this proposed mechanism. Tyr167 is located
such that it might act as the base that donates the proton
to the alkoxide ion in the catalytic mechanism, whereas
Lys171 might act to stabilize a transition state and/or
effect the pKa of the Tyr167 hydroxyl group. The third
member of the proposed catalytic triad, Ser154, is located
at the active site and is positioned such that it could inter-
act with the keto group of the substrate and/or alkoxide
ion of the transition state.
Structural similarities between BKR and other members of
the SDR family 
The program PROTEP [14] was used to compare the
three-dimensional coordinates of BKR with those of all
other proteins in the Protein Data Bank (PDB) [15]. Simi-
larities were found to numerous dehydrogenases, but a
very strong similarity was shown between BKR and other
members of the SDR family, notably trihydroxynaphtha-
lene reductase [16] (THNR; PDB entry 1YBV), tropinone
reductase II [17] (TROP; PDB entry 2AE2) and mouse
lung carbonyl reductase [18] (MLCR; PDB entry 1CYD).
There is a good superposition of helices α1, α2, α3, α4, α5
and α7, the central β sheet and six of the 14 intervening
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Figure 2
Structure-based multiple alignment of BKR sequences. The conserved
residues are shaded and the elements of secondary structure from the
Brassica napus enzyme are shown above the alignment as labelled
cylinders (α helices) and arrows (β strands). Sequences are aligned
from six organisms: BRANA, Brassica napus; ARATH, Arabidopsis
thaliana; CUPLA, Cuphea lanceolata; ECOLI, Escherichia coli; VIBHA,
Vibrio harveyi; HAEIN, Haemophilus influenzae. (The figure was
produced using CINEMA [34] and ALSCRIPT [38].)
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turns in BKR with the equivalent regions of these other
SDR enzymes, such that root mean square deviation
(rmsd) values of 0.79 Å, 1.09 Å and 1.02 Å are found for
the fitting of 191 Cα atoms in THNR, TROP and MLCR,
respectively. In addition, the superimposition results in a
good overlap of the sidechains of the equivalent catalytic
serine, tyrosine and lysine residues (BKR Ser154, Tyr167,
Lys171; THNR Ser164, Tyr178, Lys182; TROP Ser146,
Tyr159, Lys163; MLCR Ser136, Tyr149, Lys153).
The search also produced good matches with the
deposited structures of the enoyl reductase enzymes from
B. napus, E. coli and Mycobacterium tuberculosis.
Structural similarity to ENR and evolutionary implications
The fatty acid elongation cycle contains two reductive
steps. The aligned sequences of the two enzymes in
B. napus that catalyze these steps, BKR and ENR, share
16% overall sequence identity over the 260 residues of
BKR (Figure 4a). ENR is composed of subunits that have
the classical dinucleotide-binding fold seen in BKR and
which also form into a closely similar tetramer [6]. The
structural similarity of binary complexes of BKR and ENR
with their respective nucleotide cofactors involves all the
secondary structure elements from both proteins apart from
helix α6 of BKR, which forms part of the nucleotide- and
substrate-binding site. There is no apparent counterpart of
BKR helix α6 in the nucleotide binary complex of ENR
where the equivalent section of polypeptide chain is a loop;
the residues of this loop were noted as having slightly ele-
vated temperature factors relative to the rest of the ENR
enzyme structure [6]. However, recent work on complexes
of an Ala138→Gly mutant of B. napus ENR with bound
nucleotide and diazaborine inhibitor compounds, which
covalently attach to the nucleotide cofactor to form a bisub-
strate analogue, have revealed that the section of polypep-
tide chain in ENR equivalent to helix α6 in BKR can refold
to adopt a helical arrangement [19]. The location of this
new helix in the ENR structure is very similar to that
observed for helix α6 in BKR. Similarly, work on E. coli
ENR has shown that it also adopts an ordered helical con-
formation in this region upon binding either diazaborine
compounds (CW Levy and JBR, unpublished observations)
or the substrate analogue triclosan [20].
The residues conserved between BKR and ENR were
plotted onto the structure of BKR. This analysis showed
some limited clustering of residues within the hydropho-
bic core of the enzyme formed by the packing of helices
α1 and α7 against the strands β1, β4, β6 and β7 of the
β sheet, but otherwise the conserved residues appear dis-
tributed throughout the secondary structure elements.
There is apparently little conservation of sequence near
the active site, with the notable exception of the putative
catalytic residue Lys171 in BKR, which corresponds to
Lys206 in ENR. The phenolic hydroxyl groups of Tyr167
in BKR and the proposed catalytic residue Tyr198 in
ENR, although not picked out by the sequence align-
ment, are also located in similar, but not identical, posi-
tions in the three-dimensional structures (Figure 4b). The
catalytic Ser154 of BKR corresponds to Tyr188 of ENR in
both the sequence alignment and the structural superim-
position, but this residue has not been shown to have a
role in the catalytic mechanism of ENR.
There is a difference of approximately 1.1 Å in the positions
of the phenolic oxygens of Tyr167 in BKR and Tyr198 in
ENR relative to the C4 position of the nicotinamide rings
of their respective cofactors. This small difference in the
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Figure 3
BKR electron-density map and reaction mechanism. (a) The electron
density for the bound NADP+ nucleotide from a map calculated at the
end of the refinement with coefficients 2|Fo|–|Fc| αcalc. The refined
coordinates of the nucleotide-bound model are shown. (The figure was
produced using the program O [39].) (b) The proposed reaction
mechanism for the reduction of 3-oxoacyl–ACP catalyzed by BKR.
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positions of the phenolic oxygens, which are believed to be
the proton donors in the reaction mechanisms of BKR and
ENR, might reflect the difference in the substrates of the
two enzymes. There are an additional two bonds separating
the site of hydride transfer and that of proton donation in
the double-bond-containing substrate of ENR compared
with the keto substrate of BKR. 
It is clear that a common underlying structure, comprising a
single domain formed from the classical dinucleotide-
binding fold, has been utilized to carry out the two reduc-
tive steps in B. napus FAS. In addition, the regions forming
the substrate-binding sites in BKR and ENR would seem
to have notable similarities in terms of the use of an α helix
to act as a flexible lid on the pocket that might occlude
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Figure 4
Sequence and structure alignments of B. napus BKR and ENR. 
(a) The aligned sequences of Brassica napus BKR and ENR with the
conserved residues shown in reverse typeface. The secondary
structure elements of BKR and ENR are shown above and below the
alignment, respectively; α helices are blue and β strands red. (The
figure was produced using CINEMA [34] and ALSCRIPT [38].)
(b) Stereoview superimposition of the Cα backbones of the active
sites of B. napus BKR (green) and ENR (red). The catalytic tyrosine
and lysine residues and bound nucleotides are shown in stick format.
(The figure was produced using MIDAS [35].)
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solvent during catalysis. Furthermore, lysine sidechains and
tyrosine phenolic hydroxyl groups that are structurally con-
served between BKR and ENR are used to carry out the
catalytic mechanisms. These structural features, taken
together with the sequence similarity distributed through-
out the polypeptide chains of the enzymes, suggest that the
two enzymes have diverged from a common reductase
ancestor in the evolution of the FAS elongation cycle.
In spite of the structural similarities in the active sites of
ENR and BKR described above, there have been no
reports of the inhibition of BKR by the triclosan, diaza-
borine or isoniazid compounds known to inhibit ENR
[20–22]. A superimposition of the active site of BKR with
that of ENR in complex with triclosan, diazaborine or iso-
niazid suggests a number of steric clashes between BKR
and these drugs plus the probable absence of certain
favourable interactions. The triclosan and diazaborine
compounds bind to ENR in an analogous manner [20,21]
and the substitution of Ala95, Met159 and Ala196 in E. coli
ENR by the equivalent residues Thr106, Tyr167 and
Met204 in B. napus BKR is likely to cause severe steric
clashes and prevent drug binding. Examination of the
superimposition of BKR with the complex of M. tuberculo-
sis ENR (also known as InhA) and a derivative of isoniazid
[22] reveals favourable interactions formed with the drug
by residues Phe149 and Tyr158 of InhA; these interac-
tions would not be replicated in B. napus BKR. 
Substrate binding by BKR
BKR binds a 3-oxoacyl substrate that is attached to coen-
zyme A or to ACP via a phosphopantotheine arm.
Attempts to model the manner in which the substrate
might be bound by the enzyme immediately reveal that
the structure adopted by the enzyme in the binary
complex observed here is not compatible with substrate
binding. In particular Met204, which is located on helix
α6 and conserved throughout the family of BKR
sequences, occupies a critical portion of the expected
binding site for the substrate. Selection of other possible
rotamers for the sidechain of Met204 still does not
provide sufficient space for substrate binding, and leads to
the conclusion that helix α6 moves to accommodate the
substrate. This idea is supported by examination of binary
complexes of TROP with the product pseudotropine
and/or an NAD+ cofactor (PDB entries 2AE2 and 1AE1).
These complexes show a similar movement of helix αG′′
(equivalent to α6 in BKR) away from the nicotinamide
ring of the cofactor and an enlargement of the substrate-
binding cleft. Using the helix movements in TROP as a
guide to possible enzyme structure rearrangement, and
the structures of diazaborine and triclosan complexes of
the related B. napus and E. coli ENRs [19–21] to guide
substrate placement, a model can be constructed for the
possible mode of binding of a 3-oxoacyl substrate to BKR
(Figure 5). This model involves movement of helix α6 as
a rigid body such that the Cα atom of Met204 is moved by
approximately 4 Å away from the bound NADP+ cofactor.
The substrate can then be accommodated in such a way
that the oxygen of the keto group reduced during catalysis
is 3.2 Å from the phenolic oxygen of the Tyr167 and only
4.2 Å from the hydroxyl of Ser154. The C3 atom of the
substrate, to which hydride transfer occurs, is also posi-
tioned so as to accept the hydride ion from a bound
NADPH cofactor. An elongating acyl chain would be
positioned in a cleft formed between the turns following
strands β5 and β6, helix α7 and the C terminus, and is
lined with residues Val155, Val156, Ile159, Phe199, Ile216
and Ile258. Further support for the modelled alteration in
the BKR protein structure comes form the recent report of
a complex of M. tuberculosis ENR with a fatty acyl sub-
strate [23] in which the region equivalent to helix α6 in
BKR is observed to move 4 Å away from the nucleotide
cofactor relative to its position in the structure of an
enzyme–NADH binary complex.
Biological implications
Fatty acid biosynthesis is a ubiquitous process catalyzed
by two distinct types of fatty acid synthetase (FAS).
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Figure 5
A model for the binding of a 3-oxoacyl-CoA substrate into the active
site of Brassica napus BKR. (a) The Cα backbones of the
crystallographically determined structure and that of a form modified to
permit substrate binding (see text) are shown in blue and yellow,
respectively. An acyl-CoA substrate was derived from the CoA
molecule in PDB entry 1BUC. The acyl-CoA substrate (cyan) and
bound nucleotide (purple) are shown in all atom representation; the
keto oxygens of acyl-CoA are in red. The catalytically important
residues, Ser154, Tyr167 and Lys171, are also shown and labelled.
(b) A molecular surface calculated for BKR (corresponding to the
modified structure with the yellow backbone trace in (a)) with bound
substrate and nucleotide. A clear channel, unaffected by the
modification of the crystallographic structure, can be seen in the top
left and might be suitable for the growing acyl chain. (The figure was
produced using the program GRASP [40].)
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Plants and many bacteria possess a type II FAS, which is
distinguished from the type I FAS found in other organ-
isms by having all the enzymes of fatty acid elongation
located on separate polypeptide chains rather than on one
or two very large multidomain polypeptides. The FAS
pathway shows notable similarities to that of polyketide
biosynthesis with many of the enzymatic steps being
common to both pathways, although their order is fre-
quently different. Polyketide biosynthesis also tends to
utilize large multidomain polypeptides in an analogous but
often more complex fashion to that seen with type I FAS.
The FAS elongation cycle contains two reductive steps
catalyzed by the enzymes β-keto acyl carrier protein
reductase (BKR) and enoyl acyl carrier protein
reductase (ENR) that perform carbon–oxygen and
carbon–carbon double-bond reductions, respectively. A
sequence homology can be seen between these enzymes
in type II FAS and the work presented here on the
structure of the plant BKR from Brassica napus has
revealed how this extends to a striking similarity in
three-dimensional structure when compared with that
of the previously determined ENR from the same
source. The structural similarity exists down to the
level of conserved functional groups of the protein that
are implicated in the proposed catalytic mechanisms
and mode of substrate binding, which involves the use
of corresponding mobile helices in the two enzymes as
lids on their binding sites. Overall a case can be made
for a strong evolutionary link between these enzymes
during the development of FAS.
Materials and methods
Crystals of BKR were grown by the hanging-drop vapour diffusion
method from buffered polyethylene glycol (PEG) solutions as
described previously [24]. The enzyme crystallizes in the space group
P6422 with cell dimensions a = b = 129.93 Å c = 93.10 Å. The crystals
have one monomer in the asymmetric unit and a solvent content of
73%. Native X-ray diffraction data to 2.3 Å resolution were collected at
room temperature on a MAR345 image plate on a Rigaku X-ray genera-
tor. The images were processed using DENZO from the HKL suite of
programs [25] and the resulting data were merged and scaled using
SCALEPACK. The native data set, obtained from one crystal, was
94.8% complete to 2.3 Å (with 72% of the data having I > 3σ(I)).
The structure was solved using a combination of molecular replacement
(MR) and multiple isomorphous replacement (MIR) techniques. An MR
solution using a model based on the structure of 3α,20β-hydroxysteroid
dehydrogenase (HSD) from Streptomyces hydrogenans [11] was
obtained. The phase information from the MR solution was supple-
mented by that from two isomorphous derivatives to produce a readily
interpretable map. The isomorphous derivatives were obtained by cova-
lently modifying the enzyme with mercury using p-chloromercuriben-
zenesulphonate (PCMBS) and ethyl mercury phosphate (EMP). The
heavy-atom sites were found by difference Fourier methods using the
phases from the MR solution. The heavy-atom parameters and the
phases calculated from them were refined using the program
MLPHARE [26]. The overall figure of merit (FOM) for PCMBS was 0.34
(acentric 0.32, centric 0.52) and for EMP was 0.44 (acentric 0.42,
centric 0.56). When they were combined, the derivatives gave an overall
FOM of 0.56 (acentric 0.55, centric 0.70).
Initial phases were calculated to 3.0 Å resolution and were improved by
solvent flattening, histogram matching and phase extension using the
program DM [27]. A preliminary trace utilizing the structure of HSD was
made and this was used as a guide for the placement of the corre-
sponding BKR residues that were fitted using the program FRODO [28]
on an Evans and Sutherland ESV workstation. The Cα positions for 214
(82%) of the residues could be located in the map and for these
residues, 160 sidechains could also be clearly interpreted with the rest
being assigned as alanine. The model was submitted to least-squares
refinement using the TNT program [29] with restraints on bond lengths
and angles, planes and non-bonded contacts and a correction for the
solvent continuum [30]. The structure was then rebuilt to the observed
density using |2Fo–Fc| maps and further refinement reduced the R factor
to 38.6 (Rfree 43.4) whereupon the resolution limit was increased to
2.3 Å. After more rounds of model building and refinement, including
refinement of individual atomic B factors, an R factor of 0.234 (Rfree
0.35) was obtained for all data (no σ cutoff) in the resolution range
10–2.3 Å. In the final stages of refinement the density map was sub-
jected to solvent molecule fitting using the program ARP [31] and the R
factor and Rfree were further reduced to 19% and 23.5%, respectively.
The data collection and refinement statistics are summarized in Table 1.
A comparison of the structure of BKR with those of all entries in the
April 1999 release of the PDB was carried out using the program
PROTEP [14]. In this procedure, BKR and the proteins in the PDB are
represented in a simplified manner as linear helices and strands in
three-dimensional space. These secondary structure elements (SSEs)
and their interrelationships are represented as a mathematical graph
[32], which is then searched using a maximal common subgraph algo-
rithm [33]. The strongest similarity with BKR was observed for THNR
(PDB entry 1YBV) where 15 SSEs were denoted as equivalent in the
two structures. Sequence alignments were carried out by inspection in
the light of knowledge of the three-dimensional structures using the
program CINEMA [34].
Accession numbers
The coordinates for the structure of B. napus BKR have been
deposited in the RCSB PDB with accession code 1EDO.
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Table 1
X-ray data collection and phasing statistics.
Data set* Native PCMBS EMP
Resolution (Å) 2.3 2.9 3.0
No. of observed reflections 102,604 57,583 37,715
No. of unique reflections 21,256 10,582 9369
Completeness overall (%)† 95 (91.5) 99 (98.6) 98 (96.8)
Rmerge overall†‡ 0.071 0.131 0.069
(0.450) (0.554) (0.280)
Fractional isomorphous§ 0.178 0.286
difference
Heavy-atom concentration (mM) 5 1
Soak
pH 4 4
time (h) 1 1
No. of heavy-atom sites 1 2
Phasing power# (acentric/centric) 1.23/1.05 1.78/1.39
RCullis (acentric/centric)¶ 0.78/0.69 0.68/0.61
*See the Materials and methods section for descriptions. †Values in
parentheses are for the highest resolution shell.
‡Rmerge = ∑hklIi–Im/∑hklIm, where Ii and Im are the observed intensity
and mean intensity of   related reflections, respectively. §Fractional
isomorphous difference = ∑FPH–FP/∑FP, where FPH and FP
are the structure-factor amplitudes for derivative and native crystals,
respectively. #Phasing power = <FH/lack of closure>. ¶RCullis = <lack of
closure>/<isomorphous difference>.
st8403.qxd  03/21/2000  03:15  Page 346
Acknowledgements
We would like to thank David Rice for helpful input throughout this work and
for critical reading of the manuscript. This work was supported by grants
from the BBSRC and The Wellcome Trust and by a Realising Our Potential
Award (ROPA) to ARS. JBR is a Royal Society Olga Kennard Fellow. MF is
a New Energy and Industrial Technology Development Organisation
(NEDO) funded researcher.
References
1. Rock, C.O. & Cronan, J.E. (1996). Escherichia coli as a model for the
regulation of dissociable (type II) fatty acid biosynthesis. Biochim.
Biophys. Acta Lipids Lipid Metab. 1302, 1-16.
2. Toomey, R.E. & Wakil, S.J. (1966). Studies on the mechanism of fatty
acid synthesis XV. Preparation and general properties of β-ketoacyl
acyl carrier protein reductase from Escherichia coli. Biochim.
Biophys. Acta 116, 189-197.
3. Sheldon, P.S., Kekwick, R.G.O., Smith, C.G., Sidebottom, C. &
Slabas, A.R. (1992). 3-Oxoacyl-[ACP] reductase from oilseed rape
(Brassica napus). Biochim. Biophys. Acta 1120, 151-159.
4. Shimakata, T. & Stumpf, P.K. (1982). Purification and
characterizations of beta-ketoacyl-[acyl-carrier-protein] reductase,
beta-hydroxyacyl-[acyl-carrier-protein] dehydrase, and enoyl-[acyl-
carrier-protein] reductase from Spinacia oleracea leaves. Arch.
Biochem. Biophys. 218, 77-91.
5. Birge, C.H. & Vagelos, P.R. (1972). Acyl carrier protein. XVI.
Intermediate reactions of unsaturated fatty acid synthesis in Escherichia
coli and studies of fabB mutants. J. Biol. Chem. 247, 4921-4929.
6. Rafferty, J.B., et al., & Rice, D.W. (1995). Common themes in redox
chemistry emerge from the X-ray structure of oilseed rape (Brassica
napus) enoyl acyl carrier protein reductase. Structure 3, 927-938.
7. Hutchinson, E.G. & Thornton, J.M. (1996). PROMOTIF — a program to
identify and analyze structural motifs in proteins. Protein Sci.
5, 212-220.
8. Birktoft, J.J. & Banaszak, L.J. (1984). Structure-function relationships
among nicotinamide-adenine dinucleotide dependent
oxidoreductases. In Peptide and Protein Reviews. (Hearn, M.T.W.,
ed), pp. 1-46, Dekker, New York.
9. Sheldon, P.S., Kekwick, R.G.O., Sidebottom, C., Smith, C.G. & Slabas,
A.R. (1990). 3-Oxoacyl-(acyl-carrier protein) reductase from avocado
(Persea americana) fruit mesocarp. Biochem. J. 271, 713-720.
10. Lee, B. & Richards, F.M. (1971). The interpretation of protein
structures: estimation of static accessibility. J. Mol. Biol. 55, 379-400.
11. Ghosh, D., Wawrzak, Z., Weeks, C.M., Duax, W.L. & Erman, M.
(1994). The refined 3-dimensional structure of 3-α,20-β-
hydroxysteroid dehydrogenase and possible roles of the residues
conserved in short-chain dehydrogenases. Structure 2, 629-640.
12. Labesse, G., Vidalcros, A., Chomilier, J., Gaudry, M. & Mornon, J.P.
(1994). Structural comparisons lead to the definition of a new
superfamily of NAD(P)(H)-accepting oxidoreductases – the single-
domain reductases/epimerases/dehydrogenases (the RED family).
Biochem. J. 304, 95-99.
13. Jornvall, H., et al., & Ghosh, D. (1995). Short-chain dehydrogenases
reductases (SDR). Biochemistry 34, 6003-6013.
14. Grindley, H.M., Artymiuk, P.J., Rice, D.W. & Willett, P. (1993).
Identification of tertiary structure resemblance in proteins using a maximal
common subgraph isomorphism algorithm. J. Mol. Biol. 229, 707-721.
15. Bernstein, F.C., et al., & Tasumi, M. (1977). The Protein Data Bank: a
computer based archival file for macromolecular structures. J. Mol.
Biol. 112, 535-542.
16. Andersson, A., Jordan, D., Schneider, G. & Lindqvist, Y. (1996).
Crystal structure of the ternary complex of 1,3,8-
trihydroxynaphthalene reductase from Magnaporthe grisea with
NADPH and an active-site inhibitor. Structure 4, 1161-1170.
17. Nakajima, K., et al., & Yamada, Y. (1998). Crystal structures of two
tropinone reductases: different reaction stereospecificities in the same
protein fold. Proc. Natl Acad. Sci. USA 95, 4876-4881.
18. Tanaka, N., Nonaka, T., Nakanishi, M., Deyashiki, Y., Hara, A. & Mitsui,
Y. (1996). Crystal structure of the ternary complex of mouse lung
carbonyl reductase at 1.8 Å resolution: the structural origin of
coenzyme specificity in the short-chain dehydrogenase/reductase
family. Structure 4, 33-45.
19. Roujeinikova, A., et al., & Rice, D.W. (1999). Inhibitor binding studies
on enoyl reductase reveal conformational changes related to substrate
recognition. J. Biol. Chem. 274, 30811-30817.
20. Levy, C.W., et al., & Rafferty, J.B. (1999). Molecular basis of triclosan
activity. Nature 398, 383-384.
21. Baldock, C., et al., & Rice, D.W. (1996). A mechanism of drug action
revealed by structural studies of enoyl reductase. Science
274, 2107-2110.
22. Rozwarski, D.A., Grant, G.A., Barton, D.H.R., Jacobs, W.R. &
Sacchettini, J.C. (1998). Modification of the NADH of the isoniazid
target (InhA) from Mycobacterium tuberculosis. Science 279, 98-102.
23. Rozwarski, D.A., Vilcheze, C., Sugantino, M., Bittman, R. & Sacchettini,
J.C. (1999). Crystal structure of the Mycobacterium tuberculosis
enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty
acyl substrate. J. Biol. Chem. 274, 15582-15589.
24. Fisher, M., et al., & Rafferty, J.B. (1999). Crystallization of the NADP-
dependent β-keto acyl-carrier protein reductase from Brassica napus.
Acta Crystallogr. D 56, 86-88.
25. Otwinowski, Z. & Minor, W. (1997). Processing of X-ray diffraction
data collected in oscillation mode. Methods Enzymol. 276, 307-326.
26. Otwinowski, Z. (1991). Maximum-likelihood refinement of heavy atom
parameters in isomorphous replacement and anomalous scattering. In
Proceedings of the CCP4 Study Weekend. (Wolf, W., Evans, P.R. &
Leslie, A.G.W. eds), pp. 80-86, SERC Daresbury Laboratory,
Warrington, UK.
27. Cowtan, K.D. & Main, P. (1993). Improvement of macromolecular
electron-density maps by the simultaneous application of real and
reciprocal space constraints. Acta Crystallogr. D 49, 148-157.
28. Jones, T.A. (1978). A graphics model building and refinement system
for macromolecules. J. Appl. Crystallogr. 11, 268-270.
29. Tronrud, D.E. (1992). Conjugate-direction minimization: an improved
method for the refinement of macromolecules. Acta Crystallogr. A
48, 912-916.
30. Moews, P.C. & Kretsinger, R.H. (1975). Refinement of the structure of
carp muscle calcium binding parvalbumin by model building and
difference Fourier analysis. J. Mol. Biol. 91, 201-228.
31. Collaborative Computational Project No.4 (1994). The CCP4 suite —
programs for protein crystallography. Acta Crystallogr. D 50, 760-
763. 
32. Mitchell, E.M., Artymiuk, P.J., Rice, D.W. & Willett, P. (1990). Use of
techniques derived from graph-theory to compare secondary structure
motifs in proteins. J. Mol. Biol. 212, 151-166.
33. Bron, C. & Kerbosch, J. (1973). Algorithm 457 — finding all cliques of
an undirected graph. Commun. ACM 16, 575-577.
34. Parry-Smith, D.J., Payne, A.W.R., Michie, A.D. & Attwood, T.K. (1998).
CINEMA — a novel colour interactive editor for multiple alignments.
Gene 221, 57-63.
35. Ferrin, T.E., Huang, C.C., Jarvis, L.E. & Langridge, R. (1988). The
MIDAS display system. J. Mol. Graph. 6, 13-27.
36. Kraulis, P.J. (1991). MOLSCRIPT — a program to produce both
detailed and schematic plots of protein structures. J. Appl. Crystallogr.
24, 946-950.
37. Merritt, E.A. & Murphy, M.E.P. (1994). Raster3D version 2.0 — a
program for photorealistic molecular graphics. Acta Crystallogr. D
50, 869-873.
38. Barton, G.L. (1993). ALSCRIPT: a tool to format multiple sequence
alignments. Protein Eng. 6, 37-40.
39. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved
methods for building protein models in electron density maps and the
location of errors in these models. Acta Crystallogr. A 47, 110-119.
40. Nicholls, A., Sharp, K.A. & Honig, B. (1991). Protein folding and
association: insights from the interfacial and thermodynamic
properties of hydrocarbons. Proteins 11, 281-296.
Research Article  β-Keto acyl carrier protein reductase Fisher et al. 347
Because Structure with Folding & Design operates a
‘Continuous Publication System’ for Research Papers, this
paper has been published on the internet before being printed
(accessed from http://biomednet.com/cbiology/str). For
further information, see the explanation on the contents page.
st8403.qxd  03/21/2000  03:15  Page 347
